Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway

This publication has 41 references indexed in Scilit:

• New agents for the treatment of acute myeloid leukemia
  Best Practice & Research Clinical Haematology, 2006
• The Requirement for and Changing Composition of the Activating Protein-1 Transcription Factor during Differentiation of Human Leukemia HL60 Cells Induced by 1,25-Dihydroxyvitamin D3
  Cancer Research, 2006
• 1α,25‐dihydroxyvitamin D₃‐mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDR_nuc‐mediated activation of the RAS/RAF/ERK‐MAP kinase signalling pathway
  Journal of Cellular Biochemistry, 2006
• Translational study of vitamin D differentiation therapy of myeloid leukemia: effects of the combination with a p38 MAPK inhibitor and an antioxidant
  Leukemia, 2005
• Vitamin D compounds in leukemia
  The Journal of Steroid Biochemistry and Molecular Biology, 2005
• Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1α,25-dihydroxyvitamin D3
  The Journal of Steroid Biochemistry and Molecular Biology, 2004
• Inhibition of p38 MAP Kinase Activity Up-Regulates Multiple MAP Kinase Pathways and Potentiates 1,25-Dihydroxyvitamin D3-Induced Differentiation of Human Leukemia HL60 Cells
  Experimental Cell Research, 2000
• The stress-activated protein kinase subfamily of c-Jun kinases
  Nature, 1994
• CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
  Science, 1990
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
  The Journal of cell biology, 1984